Seoul, Seoul-t'ukpyolsi, South Korea InterVest Co. is the famous VC, which was founded in 1999. The venture was found in Asia in South Korea. The main department of described VC is located in the Seoul.
The usual cause for the fund is to invest in rounds with 5-6 partakers. Despite the InterVest Co., startups are often financed by Softbank Ventures Asia, Samsung Ventures, Mirae Asset Venture Investment. The meaningful sponsors for the fund in investment in the same round are Mirae Asset Venture Investment, Legend Capital, WONIK Investment Partners. In the next rounds fund is usually obtained by Samsung Ventures, WONIK Investment Partners, Translink Capital.
The important activity for fund was in 2019. Considering the real fund results, this VC is 13 percentage points more often commits exit comparing to other organizations. The fund is constantly included in 2-6 deals per year. The common things for fund are deals in the range of 10 - 50 millions dollars.
For fund there is a match between the country of its foundation and the country of its the most frequent investments - South Korea. Besides, a startup needs to be aged 4-5 years to get the investment from the fund. Among the most popular fund investment industries, there are Medical Device, EdTech. The fund has exact preference in some founders of portfolio startups. In case when startup counts 3 or 4 of the founder, the chance for it to get the investment is meager. Among the most popular portfolio startups of the fund, we may highlight Pomelo Fashion, Noom, MAXST.
Related Funds
| Fund Name | Location |
| Asahi Kasei Corporate Venture Capital | California, Menlo Park, United States |
| Beijing Yisheng Innovation Technology | Beijing, Beijing, China |
| CCIAA Pisa | - |
| DIventures | Switzerland, Zürich, Zurich |
| Kitara Capital | Masqat, Muscat, Oman |
| Mad'a Investment Company | Ar Riyad, Riyadh, Saudi Arabia |
| Open Source Syndicate | California, San Francisco, United States |
| Shanghai Shangchuang Xinwei Investment Management | - |
| Steadfast Financial | New York, New York, United States |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Phantom AI | $36M | 01 Feb 2023 | California, United States | ||
Databank | 09 Dec 2022 | South Korea, Gyeonggi-do, South Korea | |||
PineTree Therapeutics | $23M | 07 Jun 2022 | Cambridge, Massachusetts, United States | ||
Innospace | $30M | 05 May 2022 | Seongnam, Kyonggi-do, South Korea | ||
Genome Insight | $23M | 30 Apr 2022 | La Jolla, California, United States | ||
ABLY Corporation | $58M | 03 Feb 2022 | Yeoksamdong, Seoul-t'ukpyolsi, South Korea | ||
NOTA | $14M | 17 Nov 2021 | Seoul, Seoul-t'ukpyolsi, South Korea | ||
N.THING | $13M | 03 Oct 2021 | South Korea, Gyeonggi-do, South Korea | ||
H2O Hospitality | $29M | 06 Sep 2021 | Chiyoda, Japan |
– Orum Therapeutics closed a $84m Series B financing.
– The financing was led by IMM Investment and joined by new investors (KDB Investment and Atinum, among others) and existing investors (Intervest and KB Investment, among others).
– Orum plans to use the proceeds to advance the Company’s lead therapeutic candidates into clinical trials, explore additional payload chemistries to develop additional payloads that modulate the ubiquitin pathway, and other general corporate purposes.
– The company has developed a new class of ADC payloads, called neoDegraders, to specifically degrade intracellular target proteins within cancer cells via the E3 ubiquitin ligase pathway.
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Phantom AI | $36M | 01 Feb 2023 | California, United States | ||
Databank | 09 Dec 2022 | South Korea, Gyeonggi-do, South Korea | |||
PineTree Therapeutics | $23M | 07 Jun 2022 | Cambridge, Massachusetts, United States | ||
Innospace | $30M | 05 May 2022 | Seongnam, Kyonggi-do, South Korea | ||
Genome Insight | $23M | 30 Apr 2022 | La Jolla, California, United States | ||
ABLY Corporation | $58M | 03 Feb 2022 | Yeoksamdong, Seoul-t'ukpyolsi, South Korea | ||
NOTA | $14M | 17 Nov 2021 | Seoul, Seoul-t'ukpyolsi, South Korea | ||
N.THING | $13M | 03 Oct 2021 | South Korea, Gyeonggi-do, South Korea | ||
H2O Hospitality | $29M | 06 Sep 2021 | Chiyoda, Japan |
Get matched with relevant funds
